Nahar K - Search Results

1

Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats.

Gupta N, Patel B, Nahar K, Ahsan F. Gupta N, et al. Among authors: nahar k. Eur J Pharm Biopharm. 2014 Nov;88(3):1046-55. doi: 10.1016/j.ejpb.2014.10.012. Eur J Pharm Biopharm. 2014. PMID: 25460151 Free PMC article.

2

Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature.

Nahar K, Absar S, Patel B, Ahsan F. Nahar K, et al. Int J Pharm. 2014 Apr 10;464(1-2):185-95. doi: 10.1016/j.ijpharm.2014.01.007. Epub 2014 Jan 21. Int J Pharm. 2014. PMID: 24463004 Free PMC article.

3

Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension.

Nahar K, Absar S, Gupta N, Kotamraju VR, McMurtry IF, Oka M, Komatsu M, Nozik-Grayck E, Ahsan F. Nahar K, et al. Mol Pharm. 2014 Dec 1;11(12):4374-84. doi: 10.1021/mp500456k. Epub 2014 Nov 4. Mol Pharm. 2014. PMID: 25333706 Free PMC article.

4

Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.

Rashid J, Nahar K, Raut S, Keshavarz A, Ahsan F. Rashid J, et al. Among authors: nahar k. Mol Pharm. 2018 May 7;15(5):1755-1765. doi: 10.1021/acs.molpharmaceut.7b01003. Epub 2018 Mar 26. Mol Pharm. 2018. PMID: 29528655 Free PMC article.

5

Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.

Nahar K, Rashid J, Absar S, Al-Saikhan FI, Ahsan F. Nahar K, et al. Pharm Res. 2016 Jul;33(7):1696-710. doi: 10.1007/s11095-016-1911-7. Epub 2016 Apr 5. Pharm Res. 2016. PMID: 27048347 Free PMC article.

6

Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.

Absar S, Nahar K, Kwon YM, Ahsan F. Absar S, et al. Among authors: nahar k. Pharm Res. 2013 Jun;30(6):1663-76. doi: 10.1007/s11095-013-1011-x. Epub 2013 Mar 7. Pharm Res. 2013. PMID: 23468049

7

In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.

Nahar K, Gupta N, Gauvin R, Absar S, Patel B, Gupta V, Khademhosseini A, Ahsan F. Nahar K, et al. Eur J Pharm Sci. 2013 Aug 16;49(5):805-18. doi: 10.1016/j.ejps.2013.06.004. Epub 2013 Jun 22. Eur J Pharm Sci. 2013. PMID: 23797056 Review.

8

Newer devices and improved formulations of inhaled insulin.

Rashid J, Absar S, Nahar K, Gupta N, Ahsan F. Rashid J, et al. Among authors: nahar k. Expert Opin Drug Deliv. 2015 Jun;12(6):917-28. doi: 10.1517/17425247.2015.990436. Epub 2014 Dec 8. Expert Opin Drug Deliv. 2015. PMID: 25485886 Review.

9

Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models.

Patel B, Gauvin R, Absar S, Gupta V, Gupta N, Nahar K, Khademhosseini A, Ahsan F. Patel B, et al. Among authors: nahar k. Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L733-47. doi: 10.1152/ajplung.00076.2012. Epub 2012 Aug 10. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22886505 Free article.

10

Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.

Absar S, Gupta N, Nahar K, Ahsan F. Absar S, et al. Among authors: nahar k. J Thromb Haemost. 2015 Sep;13(9):1545-56. doi: 10.1111/jth.13033. Epub 2015 Jul 27. J Thromb Haemost. 2015. PMID: 26074048 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters